Laura Navika Yamani
Overview
Explore the profile of Laura Navika Yamani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamani L, Astutik E, Qurniyawati E, Lusida M, Getaneh Y, Kelly M
BMC Public Health
. 2025 Feb;
25(1):738.
PMID: 39987067
Sexually Transmitted Infections (STIs) seriously affect population morbidity, mortality, and are a major public health problem worldwide. A cross-sectional study was conducted using the latest Demographic and Health Survey (DHS)...
2.
Fitria A, Dinana Z, Maharani A, Fumizuki A, Mumtazya F, Atmaka D, et al.
J Infect Public Health
. 2025 Feb;
18(4):102687.
PMID: 39933424
Background: Norovirus infection is the second most frequent viral agent causing gastroenteritis worldwide. Asymptomatic norovirus infection is prevalent in children and is associated with growth failure. Evaluating the intestinal inflammation...
3.
Dinana Z, Doan Y, Maharani A, Fitria A, Yamani L, Juniastuti , et al.
J Med Virol
. 2024 Dec;
96(12):e70106.
PMID: 39670413
Inter-genogroup reassortment of Rotavirus A (RVA) strains has highlighted the spread of unusual RVA strains worldwide. We previously reported the equine-like G3 RVA as the predominant strain in Indonesia in...
4.
Churrotin S, Amarullah I, Fitria A, Khairunisa S, Yamani L, Kameoka M, et al.
Heliyon
. 2024 Nov;
10(21):e39099.
PMID: 39524770
Background: The simultaneous occurrence of the COVID-19 pandemic and a dengue outbreak has posed significant challenges for governments and medical personnel in dengue-endemic countries like Indonesia. Several studies in dengue-endemic...
5.
Yamani L, Juniastuti , Megasari N, Utsumi T, Sahila N, Pangestika A, et al.
J Public Health Afr
. 2024 Jan;
14(12):2697.
PMID: 38204804
Indonesia began deploying a COVID-19 vaccine in January 2021, prioritising vaccination for high-risk groups such as healthcare workers, the elderly and those with comorbidities, and ending with the general public...
6.
Juniastuti , Utsumi T, Yamani L, Dinana Z, Gunawan E, Maharani A, et al.
J Med Virol
. 2023 Oct;
95(10):e29164.
PMID: 37830640
Norovirus (NoV) is a leading cause of epidemic and sporadic gastroenteritis in people of all ages. Humans are the primary source of NoV and household contact is one of the...
7.
Megasari N, Yamani L, Juniastuti J, Lusida M, Mori Y
PeerJ
. 2023 Oct;
11:e16142.
PMID: 37780375
Background: To limit the SARS-CoV-2 transmission, the Indonesian government launched a COVID-19 vaccination program in January 2021. Studies on the clinical treatment and implementation of COVID-19 vaccination have shown promising...
8.
Dhamanti I, Suwantika A, Adlia A, Yamani L, Yakub F
Int J Gen Med
. 2023 Feb;
16:609-618.
PMID: 36845341
The COVID-19 pandemic had a severe global impact. A range of campaigns and activities, including vaccines, are being implemented to counteract this pandemic. Using observational data, the goal of this...
9.
Yamani L, Utsumi T, Doan Y, Fujii Y, Dinana Z, Wahyuni R, et al.
J Med Virol
. 2023 Jan;
95(2):e28485.
PMID: 36625390
Rotavirus A (RVA) is a major viral cause of acute gastroenteritis (AGE) worldwide. G12 RVA strains have emerged globally since 2007. There has been no report of the whole genome...
10.
Putri W, Yano Y, Yamani L, Liang Y, Mardian Y, Utsumi T, et al.
Mol Med Rep
. 2022 Jun;
20(1):16-24.
PMID: 35706154
Mutations in the hepatitis B virus (HBV) X region and truncation of the preS2 region are well‑known to affect the progression of liver disease. Recently, it has been observed that...